Airway medicaments

Abstract

Described herein are compositions, methods, kits and devices for the treatment and/or prevention upper respiratory tract and peripheral auditory system conditions. In particular, bacterial populations described herein are live, purified bacteria for the modulation, restoration and/or promotion of the microbiome in the upper respiratory tract of a subject, including the nasal cavity, to promote health. Such bacterial populations may include single or multiple strains for bacteria. The multiple strains of bacteria may be strains from the same or different species, including species of Corynebacterium and/or Dolosigranulum pigrum.

Dependencies are inferred from the claim text.